Amanote Research
Register
Sign In
Meningococcal Conjugate Vaccines Policy Update: Booster Dose Recommendations
Pediatrics
- United States
doi 10.1542/peds.2011-2380
Full Text
Open PDF
Abstract
Available in
full text
Categories
Child Health
Pediatrics
Perinatology
Date
November 28, 2011
Authors
Unknown
Publisher
American Academy of Pediatrics (AAP)
Related search
Factors Contributing to the Immunogenicity of Meningococcal Conjugate Vaccines
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Effects of Alum Adjuvant or a Booster Dose on Immunogenicity During Clinical Trials of Group B Streptococcal Type III Conjugate Vaccines
Infection and Immunity
Parasitology
Infectious Diseases
Immunology
Microbiology
Vaccines Against Meningococcal Disease
Jornal de Pediatria
Child Health
Pediatrics
Perinatology
Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Tetanus Toxoid-Conjugate Vaccine (MenACYW-TT) in Adolescents and Adults: A Phase III Randomized Study
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Pin82 - In Small Doses: Missing the Booster Dose in a Reduced Pneumococcal Conjugate Vaccination Schedule
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
CONCURRENT ADMINISTRATION OF ROUTINE PEDIATRIC VACCINES WITH COMVAX™[HAEMOPHILUS B CONJUGATE (MENINGOCOCCAL PROTEIN CONJUGATE) AND HEPATITIS B(RECOMBINANT) VACCINE] † 785
Pediatric Research
Child Health
Pediatrics
Perinatology
Conjugate Vaccines forStreptococcus Pneumoniae
Canadian Journal of Infectious Diseases
Summary of the National Advisory Committee on Immunization’s Update on Quadrivalent Meningococcal Vaccines Available in Canada
Canada Communicable Disease Report
The Global Evolution of Meningococcal Epidemiology Following the Introduction of Meningococcal Vaccines
Journal of Adolescent Health
Mental Health
Child Health
Public Health
Perinatology
Environmental
Psychiatry
Pediatrics
Occupational Health
